• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/18/2021
Event Type  Injury  
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a model #icv1209 perceval heart valve at the time of manufacture and release.Based on the information available and medical judgment received, the root cause of the reported event can be traced to an intraoperative mis-sizing (use error).No device malfunctions occurred and no adverse event/serious injury for the patient occurred.As such, no further investigation is warranted at this time.
 
Event Description
The manufacturer was informed of the event through the patient tracking department.Based on the information reported in the patient implant form, a perceval valve pvs23 was implanted and explanted on the same day on (b)(6) 2021.Another perceval valve pvs25 was finally implanted.The manufacturer did not receive any allegation of a device malfunction nor of a serious injury from the site regarding this event.Based on the additional information received, the patient underwent a mitral valve repair, aortic valve replacement, atriclip left auricular appendage.After the pvs23 valve implant, on separating from bypass, there was echocardiographic evidence of valve undersizing of the aortic valve.A short additional cross clamp bypass run therefore undertaken and a perceval pvs25 was ultimately implanted.Per medical judgment received, the pvs23 valve was explanted intraoperatively due to incorrect initial size and there was no device malfunction identified.The patient had a good outcome.The explanted device is retained by the site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
MDR Report Key12602569
MDR Text Key278153134
Report Number3019892983-2021-01021
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)210923
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 09/10/2021,10/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/23/2021
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/10/2021
Device Age3 YR
Event Location Hospital
Date Report to Manufacturer09/10/2021
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/09/2021
Date Device Manufactured09/23/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
-
-